Navigation Links
Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council
Date:5/19/2009

LIBERTYVILLE, Ill., May 19 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy has just launched a new Medical Advisory Council (MAC). The Families of SMA MAC is one of the most highly respected bodies of SMA medical and clinical experts in the U.S., setting the agenda for proactive, creative, and collaborative leadership on issues that improve the quality of medical care for those affected by SMA.

The new Council will focus on educating families, health care providers, and the public about SMA; expanding SMA standards of care; and translating positive research results into clinical practice. Dr. Mary Schroth, a leading pediatric pulmonologist will serve as Chair for the new Council. Mary is Associate Professor of Pediatrics and Director of the Pediatric Pulmonary Center Grant at the University of Wisconsin Children's Hospital.

The MAC is composed of experts in the following fields:

Neurology (pediatric and adult); Pediatrics; Pulmonology; Pediatric Orthopedic Surgery; Pediatric Critical Care (NICU specialist); Physiatry (rehab medicine); Psychology; Genetic Counseling and/or Medical Ethics; Physical Therapy; Occupational Therapy; Diet and Nutrition; Respiratory Therapy; Nursing.

The members of the new MAC will be present at the upcoming 25th Anniversary Conference to be held in Cincinnati, OH in June.

Members of the new MAC include:

    -Susan Apkon, MD.  The Children's Hospital, Colorado.
    -Thomas Crawford, MD.  Johns Hopkins University.
    -Richard S. Finkel, MD.  The Children's Hospital of Philadelphia
    -Albert Freedman, Ph.D.  West Chester, PA.
    -Robert Graham, MD.  Children's Hospital Boston.
    -John Grayhack, MD.  Northwestern University Feinberg School of Medicine.
     Children's Memorial Hospital.
    -John T. Kissel, MD.  The Ohio State University.
    -Richard M. Kravitz, MD.  Duke University Medical Center.
    -Kristin J. Krosschell, PT, MA, PCS.  Feinberg School of Medicine,
     Northwestern University.
    -Garey Noritz, MD.  MetroHealth Medical Center/Case Western Reserve
     University.
    -Karen Patterson, MS, PT, PCS.  University of Wisconsin Physical Therapy
     Program.
    -Richard Shell, MD. Nationwide Children's Hospital and The Ohio State
     University.
    -Kenneth Silver, MD.  University of Chicago Comer Children's Hospital.
    -Brian Snyder, MD, Ph.D.  Harvard Medical School and  Children's Hospital
     of Boston.
    -Jodi Wolff, MS, RD.  MetroHealth Medical Center/Case Western Reserve.
    -Andreas Constantinescu, MD, Ph.D.  Columbia University/Children's
     Hospital of NY-Presbyterian.
    -Susan Iannaccone, MD.  University of Texas Southwestern Medical Center.
     Children's Medical Center
    -Jonathan Finder, MD.  University of Pittsburgh School of Medicine and
     Children's Hospital of Pittsburgh.
    -Petra Kaufmann, MD.  Columbia University.
    -Anastassios C. Koumbourlis, MD, MPH.  Schneider Children's Hospital.
     Albert Einstein College of Medicine.
    -Jo Anne Maczulski, MA, OTR/L.  Chicago, IL.
    -Barry S. Russman, MD.  The Ohio State University and Shriners Hospital
     for Children.
    -Kathryn J. Swoboda, MD.  University of Utah School of Medicine.
    -Nanci Yuan, MD.  Stanford University.

About Families of SMA:

Families of Spinal Muscular Atrophy is dedicated to creating a treatment and cure by:

Funding and advancing a comprehensive research program; Supporting SMA families through networking, information and services; Improving care for all SMA patients; Educating health professionals and the public about SMA; Enlisting government support for SMA; Embracing all touched by SMA in a caring community.

Our vision is a world where Spinal Muscular Atrophy is treatable and curable.

The goal of the organization for 2009 is to have raised $50 million for SMA research. Families of SMA funds and directs the leading SMA research programs. Families of SMA has created hope for our community that did not exist in 1984. Our support comes from generous individual donations and numerous fundraising events held by volunteer families and our chapters.

Our successful results and progress from basic research to drug discovery programs to clinical trials provides real hope for families and patients:

    -Families of SMA has funded 5 multi-center clinical trials for existing
     drugs that have potential for SMA.
    -FSMA has directed and funded the leading new drug development program for
     a therapy specially designed to treat SMA.
    -Families of SMA is building a pipeline of drug discovery programs based
     on our investments in basic research.
    -FSMA has invested significant resources into alternative approaches that
     show promise to cure SMA.

www.curesma.org


'/>"/>
SOURCE Families of Spinal Muscular Atrophy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Heinz Family Philanthropies (www.heinzfamily.org) Release New Facts About Cards, Highlighting Questions Families Should Ask About Long-Term Care -- 10 Questions to Answer... (www.tenquestionstoanswer.org)
2. New Study Finds Fewer Families Can Afford Health Insurance
3. 200 Families of Children With Serious Eye Problems Benefit From Unique Gift Card Program at The Vision Center at Childrens Hospital Los Angeles
4. Four of Five Families Will Be Touched by Stroke in 2009
5. DaVita Donates More Than $1 Million in Scholarship Funds for Teammates Families
6. Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for Americas Health
7. U.S. Representatives Hill and Murphy Introduce the Men and Families Health Care Act of 2009
8. Red Cross Urges Families and Communities to Prepare During Swine Flu Outbreak
9. Organ Donor Families, Transplant Recipients Journey to State Capitol to Urge Passage of Key Donor Designation Legislation
10. TERI Offers Comprehensive Life Quality Plans to Families, Caregivers of People with Developmental Disabilities
11. LFAGW to Offer Free Lupus Symposium on May 16 for Patients and Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: